Pneumonia: historical flashback and unresolved questions of classification

Abstract

The most important trends in the development of pneumonia teachings were analyzed. Historical aspects of the study and evolution of pneumonia treatments from ancient times to the present day is considered in the context of the classification of the disease and the prospects for further improving diagnostic techniques, strategies and tactics of the treatment of pneumonia. Significant scientific advances in the diagnosis and treatment of this disease over the past century were demonstrated. Attention was drawn to the necessity of system clarity of generally accepted views, which set in the modern domestic pulmonology against pneumonia. It was stressed that the clinician is often in a difficult situation, not only in the practical use of recommendations for the diagnosis and treatment of pneumonia, but when he formulates a diagnosis. The question of imperfection of existing terminology in relation to the classification of pneumonia, proposed by the European Respiratory Society and currently used in Russia was raised. It was shown the necessity to create a domestic classification of pneumonia. Especially because we already had the experience of using the N.S. Molchanov’s classification, which remained for many years because of its simplicity and versatility unique and essentially completely acceptable and relevant today. It is shown that predicting the future course of evolution in the diagnosis and treatment of pneumonia, the most important and long overdue would be a shift from an empirical antibiotic therapy to targeted therapy with effective eradication of the causative agent.

Keywords

pneumonia / diagnosis of pneumonia / classification of pneumonia / treatment of pneumonia / the prospects for the study and treatment of pneumonia

References

[1] Василенко, В.Х. Крупозное воспаление лёгких / В.Х. Василенко. – Киев: Госмедиздат УССР, 1947. – 55 с.

[2] Вотчал, Б.Е. Очерки клинической фармакологии / Б.Е. Вотчал. – М.: Медицина, 1965. – 176 с.

[3] Гембицкий, Е.В. Военно-полевая терапия / Е.В. Гембицкий, Ф.И. Комаров. – М.: Медицина, 1983. – 256 с.

[4] Ермольева, З.В. Антибиотики, интерферон, бактериальные полисахариды / З.В. Ермольева. – М.: Медицина. 1968. – 243 с.

[5] Лахтин, М.Ю. Этюды по истории медицины / М.Ю. Лахтин. – СПб, 1907. – 127 с.

[6] Молчанов, Н.С. Острые пневмонии / Н.С. Молчанов. – Л.: Медицина, 1965. – 207 с.

[7] Молчанов, Н.С. Клиника и лечение острых пневмоний / Н.С. Молчанов, В.В. Ставская. – Л.: Медицина, 1971. – 295 с.

[8] Сильвестров, В.П. Пневмония: исторические аспекты и современность / В.П. Сильвестров // Терапевтический архив. – 2003. – № 9. – С. 63–69.

[9] Цинзерлинг, В.Д. Острые пневмонии: морфология, морфогенез и вопросы патогенеза острых пневмоний / В.Д. Цинзерлинг. – М.: Медгиз, 1961. – 92 с.

[10] Цинзерлинг, В.Д. Патологическая анатомия острых пневмоний разной этиологии / В.Д. Цинзерлинг, А.В. Цинзерлинг. – Л.: Медицина, 1963. – 123 с.

[11] Чистович, Н.Я. Курс частной патологии и терапии внутренних болезней. Вопросы клиники и патологии заболеваний лёгких: В 2 т. / Н.Я. Чистович. – Петроград, 1922. – Т. 1. – 457 с.

[12] Чучалин, А.Г. Внебольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике / А.Г. Чучалин А.Г. [и др.] // Клиническая микробиология и антимикробная химиотерапия. – 2006. – Т. 8, № 1. С. 54–86.

[13] 13 . Andes , D. Applications of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections / D. Andes et al. // Clin Lab Med. – 2004. – № 24. – P. 477–502.

[14] Bartlett, J.G. Guidelines from the Infections Diseases Society of America. Practice guidelines for the management of community-acquired pneumonia in adults / J.G. Bartlett, S.F. Dowell, L.A. Mandell // Clin. Infect. Dis. – 2000. – Vol. 31. – P. 347–382.

[15] British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults admitted to hospital // Br. J. Hosp. Med. – 1993. – Vol. 49. – P. 346–350.

[16] Calbo, E. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of community-acquired respiratory tract infections / E. Calbo, J. Garau // Respiration. – 2005. – Vol. 72. – P. 561–571.

[17] ERS Task ForceReport. Guidelines for the management of adult community-acquired lower respiratory tract infections // Eur. Respir. J. – 1998. – Vol. 11. – Р. 986–991.

[18] Ewig, S. Severe community–acquired pneumonia: assessment of severity criteria / S. Ewig, M. Ruiz, J. Mensa // Am. J. Respir. Crit. Care Med. – 1998. – Vol. 158. – Р. 1102–1108.

[19] Huchon, G. Guidelines for management of community-acquired lower respiratory tract infections. European Study Communityacquired Pneumonia (ECOCAP) / G. Huchon, M. Woodhead // Committee. Eur. Respir. J. – 1998. – № 11. – P. 986–991.

[20] Mandell, L.A. Antimicrobial treatment of community-acquired pneumonia in adults: a conference report. Canadian Community- Acquired Pneumonia Consensus Conference Group / L.A. Mandell, M.S. Niderman // Can. J. Infect. Dis. – 1993. – № 4. – P. 25–51.

[21] Niderman, M.S. Guidelines for the initial empiric therapy of community-acquired pneumonia: proceedings of an American Thoracic Society Consensus Conference / M.S. Niderman, J.B. Bass, G.D. Campbell // Am. Rev. Respir. Dis. – 1993. – № 148. – P. 1418–1426.

[22] Niederman, M. S. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention / M.S. Niederman, L.A. Mandell, A. Anzueto // Am. J. Respir. Crit. Care Med. – 2001. – Vol. 163. – P. 1730–1754.

[23] Woodhead, M. Guidelines for the management of adult lower respiratory tract infections / M. Woodhead, F. Blasi, S. Ewig // Eur. Respir. J. – 2005. – № 26. – P. 1138–1180.

[24] Wunderink, R. G. Pneumonia. In: Encyclopedia of respiratory medicine / R.G. Wunderink, G.M. Mutlu, G.J. Laurent // The Boulevard, Langford Lane, Kidlington, Oxford, UK. – 2006. – Vol. 3. – P. 402–407.

RIGHTS & PERMISSIONS

Eco-Vector